Delivery Order SPE2DB22D1103-SPE2DB25FTFX2

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,869.14 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The award has an ultimate completion date of January 28, 2025 and is not designated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.28 Firm Fixed Price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical supplies. The award has an ultimate completion date of February 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, medical devices used in diabetes management. The award is a Delivery Order with a Firm Fixed Price of $1,855.98 and a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,557.74, is for the delivery of OMNIPOD 5 DEXG7G6 INTRO(GEN 5)S medical devices. The contract has a completion date of February 28, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and is an open competition award. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for OMNIPOD 5 DEXCOM G7 PODS (GEN 5) 5S medical devices. The $7,474.94 firm fixed-price award has a completion date of January 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $3,419.95. The contract is a firm fixed-price delivery order with a period of performance extending to February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,989.64 firm fixed-price delivery order is for the supply of 4,567,198,741 OMNIPOD DASH PODS (GEN 4) 5PK 5S, with a period of performance through February 10, 2025. The award is not designated as a set-aside and represents a delivery order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device. The contract has a ceiling value of $2,387.04 and a completion date of February 21, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The award, valued at $1,845.82, is for the procurement of OMNIPOD DASH PODS (GEN 4) 5PK 5S, a type of medical device used in the management of diabetes. The contract does not have a set-aside designation, indicating open competition. As a major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,618.58, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTFX2
    Delivery Order

This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTFX2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,890.85 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/1/25, 3:28 AM